Control of p21Cip by BRCA1-associated protein is critical for cardiomyocyte cell cycle progression and survival

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Cornelia Volland - , University of Göttingen (Author)
  • Peter Schott - , University of Göttingen, Klinikum Werra-Meißner GmbH (Author)
  • Michael Didié - , University of Göttingen, Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Author)
  • Jörg Männer - , University of Göttingen (Author)
  • Bernhard Unsöld - , University of Göttingen, University of Regensburg (Author)
  • Karl Toischer - , University of Göttingen, Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Author)
  • Carla Schmidt - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute), Martin Luther University Halle-Wittenberg (Author)
  • Henning Urlaub - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute), University of Göttingen (Author)
  • Katrin Nickels - , University Medical Center Göttingen, Siemens AG, AstraZeneca (Author)
  • Ralph Knöll - , University Medical Center Göttingen, Karolinska Institutet, Medical University of Graz (Author)
  • Albrecht Schmidt - , University of Göttingen, TUD Dresden University of Technology (Author)
  • Kaomei Guan - , Institute of Pharmacology and Toxicology, University Medical Center Göttingen, University of Göttingen (Author)
  • Gerd Hasenfuß - , University of Göttingen, Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Author)
  • Tim Seidler - , University of Göttingen, Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Author)

Abstract

Aims: Identifying the key components in cardiomyocyte cell cycle regulation is of relevance for the understanding of cardiac development and adaptive and maladaptive processes in the adult myocardium. BRCA1-associated protein (BRAP) has been suggested as a cytoplasmic retention factor for several proteins including Cyclin-dependent-kinase inhibitor p21Cip. We observed profound expressional changes of BRAP in early postnatal myocardium and investigated the impact of BRAP on cardiomyocyte cell cycle regulation. Methods and results: General knockout of Brap in mice evoked embryonic lethality associated with reduced myocardial wall thickness and lethal cardiac congestion suggesting a prominent role for BRAP in cardiomyocyte proliferation. αMHC-Cre driven cardiomyocyte-specific knockout of Brap also evoked lethal cardiac failure shortly after birth. Likewise, conditional cardiomyocyte-specific Brap deletion using tamoxifen-induced knockout in adult mice resulted in marked ventricular dilatation and heart failure 3 weeks after induction. Several lines of evidence suggest that Brap deletion evoked marked inhibition of DNA synthesis and cell cycle progression. In cardiomyocytes with proliferative capacity, this causes developmental arrest, whereas in adult hearts loss of BRAP-induced apoptosis. This is explained by altered signalling through p21Cip which we identify as the link between BRAP and cell cycle/apoptosis. BRAP deletion enhanced p21Cip expression, while BRAP overexpression in cardiomyocyte-specific transgenic mice impeded p21Cip expression. That was paralleled by enhanced nuclear Ki-67 expression and DNA synthesis. Conclusion: By controlling p21Cip activity BRAP expression controls cell cycle activity and prevents developmental arrest in developing cardiomyocytes and apoptosis in adult cardiomyocytes.

Details

Original languageEnglish
Pages (from-to)592-604
Number of pages13
JournalCardiovascular research
Volume116
Issue number3
Publication statusPublished - 1 Mar 2020
Peer-reviewedYes

External IDs

PubMed 31286143

Keywords

Keywords

  • BRAP, Cardiac development, Cardiomyocyte proliferation, Cell cycle, Knockout mice, p21